NovaBay Pharmaceuticals, Inc. (NBY) has 127 open-market insider trades by 47 insiders since 2006. The most active filer is Ramin Najafi, CEO & 10%.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Pioneer Pharma (Singapore) Pte. Ltd. | 10% Owner | — | 3 | $8.8M | 2016-09-22 |
| Pioneer Pharma Holdings Ltd China | 10% | — | 5 | $6.3M | 2014-05-13 |
| Jian Ping Fu | 10% Owner | — | 2 | $6.1M | 2020-08-01 |
| Pioneer Pharma (Hong Kong) Co Ltd | 10% Owner | — | 2 | $5.9M | 2019-06-11 |
| Xinzhou Li | 10% | — | 4 | $2.9M | 2013-09-20 |
| Area Pioneer Pharma Co. Ltd. Naqu | 10% | — | 1 | $1.5M | 2012-10-31 |
| J. Nutie Dowdle | Dir | — | 3 | $692K | 2006-11-10 |
| Audrey Kunin | CPO | — | 8 | $421K | 2022-12-06 |
| Jeffrey Kunin | Pres | — | 8 | $421K | 2022-12-06 |
| Robert L. Calvert III | Dir | — | 1 | $390K | 2006-05-03 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Jad Fakhry | 10% | Buy | $16K | 2025-04-02 |
| Poplar POINT Capital Partners L.P. | 10% | Buy | $75K | 2025-03-26 |
| Jad Fakhry | 10% | Buy | $31K | 2025-03-18 |
| Poplar POINT Capital GP LLC | 10% | Buy | $39K | 2025-03-10 |
| Jad Fakhry | 10% | Buy | $30K | 2025-02-25 |
| Jad Fakhry | 10% | Buy | $56K | 2025-02-03 |
Companies that share insiders with NBY, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Point Capital Management Llc Poplar | 10% | Buy | $68K | 2025-01-27 |
| Jeffrey Kunin | President & DERMAdoctor +1 | Sell | $2 | 2022-12-06 |
| Jeffrey Kunin | President & DERMAdoctor +1 | Sell | $13K | 2022-11-21 |
| Audrey Kunin | Chief Product Officer | Sell | $47K | 2022-09-14 |
| Justin Hall | CEO & Director | Buy | $2K | 2022-09-14 |
| Justin Hall | CEO & Director | Buy | $30K | 2021-12-06 |
| Audrey Kunin | Chief Product Officer | Buy | $47K | 2021-12-03 |
| Andrew D. Jones | CFO | Buy | $20K | 2021-12-03 |
| Audrey Kunin | CPO | Buy | $252K | 2021-12-02 |